Persevere Therapeutics

Persevere Therapeutics is a clinical-stage pharmaceutical company that develops novel therapeutics for effective cancer treatments.

Health and bio

Persevere Therapeutics raised $1.5M in a Seed round announced March 3, 2026, according to Technical.ly.

Founders and team

• GB
  Greg Bosch Founder

  source: crunchbase.com

Raise history

1. March 3, 2026
   Seed · $1.5M
   Source: Technical.ly

Related bio health companies

• SSharp$328K · Oct 1, 2026
• MM-BasedOct 1, 2026
• AAyna HealthOct 1, 2026
• VVytalYou$830K · Sep 30, 2026
• LLindera USSep 29, 2026
• OOrtet$500M · Sep 29, 2026
• AAptadir Therapeutics$45M · Sep 29, 2026
• GGoerSep 29, 2026

Every amount links to the page it came from. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/persevere-therapeutics.